Ascentage Pharma Group International: updates and filings

AAPGNASDAQHealthcare · Pharmaceutical Preparations

Price

$11.97

November 20, 2026Market cap $1.1B

What Ploutos Investor adds for Ascentage Pharma Group International

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 4 fiscal years, from 2022
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

What comes next, and what happened

Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.

Its SEC filings

What it has filed lately, newest first, linked to the document itself.

Apr 29, 2026 latest annual
  • Nov 18, 2026Current report (foreign company) (amendment)
    Form6-K/A
  • Nov 16, 2026Current report (foreign company)
    Form6-K
  • Nov 5, 2026Current report (foreign company)
    Form6-K
  • Oct 28, 2026Current report (foreign company)
    Form6-K
  • Oct 22, 2026Current report (foreign company)
    Form6-K
  • Oct 21, 2026Current report (foreign company)
    Form6-K
  • Oct 15, 2026Current report (foreign company)
    Form6-K
  • Sep 29, 2026Current report (foreign company)
    Form6-K
  • Sep 17, 2026Current report (foreign company)
    Form6-K
  • Aug 20, 2026Current report (foreign company)
    Form6-K
  • Aug 13, 2026Current report (foreign company)
    Form6-K
  • Aug 5, 2026Current report (foreign company)
    Form6-K
  • Aug 3, 2026Current report (foreign company)
    Form6-K
  • Jul 27, 2026Current report (foreign company)
    Form6-K
  • Jul 20, 2026Current report (foreign company)
    Form6-K
  • Jul 20, 2026REGISTRATION STATEMENT
    FormF-3ASR
  • Jul 13, 2026Current report (foreign company)
    Form6-K
  • Jun 30, 2026Current report (foreign company)
    Form6-K
  • Jun 15, 2026Current report (foreign company)
    Form6-K
  • Jun 12, 2026Current report (foreign company)
    Form6-K
  • Jun 10, 2026Current report (foreign company)
    Form6-K
  • Jun 1, 2026Current report (foreign company)
    Form6-K
  • May 28, 2026Current report (foreign company)
    Form6-K
  • May 28, 2026Current report (foreign company)
    Form6-K
  • May 22, 2026Current report (foreign company)
    Form6-K

From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Jun 14, 2024.

The full analysis

What do Ascentage Pharma Group International's filings show?

The filings are where every one of Ascentage Pharma Group International's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

All filings on EDGAR

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.